.svg){kind=icon}
.svg){kind=icon}
.png)
.svg){kind=icon}
.svg){kind=icon}
APhA DRUGInfoLINE®
.jpg)
Title Details
2019 © American Pharmacists Association
L. Michael Posey, BPharm
Pharmacy/Pharmacology
Additional Details
Newly updated, completely revamped and substantially improved, the APhA DrugInfoLINE® is a monthly newsletter of interpreted drug and pharmacotherapeutic information designed to keep front line pharmacists current on the latest trends in the biomedical literature. This unique STAT!Ref resource contains current, searchable information not available in any other similarly compiled format.
Available in the convenient, cross-searchable STAT!Ref platform, APhA DrugInfoLINE includes regular coverage of these areas:
- Neurology
- Psychiatry
- Cardiology: Focus on Lipids Care; Focus on Anticoagulation Care
- Respiratory: Focus on Asthma Care
- Gastroenterology
- Nephrology
- Endocrinology: Focus on Diabetes Care
- Rheumatology
- Infectious Diseases: Focus on HIV Care; Focus on Immunizations
- Oncology
Self-Care:
- Alternative Medicines Corner
- OTC Medicines Corner
Personalized Care:
- Drug Interactions Corner
- Pharmacogenomics Corner
Medication Monitor:
- New Drug Approvals
- Supplemental Approvals
- Alerts and Recalls
- Product Withdrawals
About the American Pharmacists Association
The American Pharmacists Association (APhA) is the organization whose members are recognized in society as essential in all patient care settings for optimal medication use that improves health, wellness and quality of life. Through information, education and advocacy, APhA empowers its members to improve medication use and advance patient care.
This title updates: Weekly
Similar Resources
Trusted References. AI-Assisted Search.
Available with a STAT!Ref subscription, STAT!Ref AI searches your licensed content and provides answers with links to sources. Connect with our team to build your institution’s collection and explore AI-assisted search.
